Biophytis (EPA:ALBPS) | WebDisclosure

REGULATED PRESS RELEASE

published on 04/24/2024 at 23:00, 2 years ago

Biophytis annonce le transfert de ses ADS sur le marché OTC
Biophytis annonce le transfert de ses ADS du Nasdaq vers le marché OTC, réduisant ainsi les coûts. Les ADS seront négociés sur OTC Pink et la demande d'admission sur OTCQB sera faite. Biophytis reste cotée sur Euronext Growth Paris

Biophytis Ads Coûts Transfert Marché OTC
REGULATED PRESS RELEASE

published on 04/24/2024 at 23:00, 2 years ago

Biophytis Announces Transfer of ADSs to OTC Market
Biophytis announces the transfer of ADSs from Nasdaq to OTC Market, resulting in cost savings. Company to trade on OTCQB while remaining listed on Euronext Growth Paris

Euronext Growth Paris Biophytis Nasdaq OTC Market ADSs
BRIEF

published on 04/19/2024 at 07:05, 2 years ago

Changement de ratio pour le programme ADR de Biophytis

Biophytis Biotechnologie Marché Boursier Ratio ADS Nouveau Ratio
BRIEF

published on 04/19/2024 at 07:05, 2 years ago

Biophytis Announces Significant Change in ADR Program Ratio

Biophytis Biotechnology Nasdaq ADR Program Stock Ratio Change
PRESS RELEASE

published on 04/19/2024 at 07:00, 2 years ago

Biophytis announces ratio change under its American Depositary Receipt (“ADR”) program
Biophytis announces ratio change for its American Depositary Receipt (ADR) program, with effective date expected to be April 23, 2024

Biophytis Stock Market American Depositary Receipt ADR Program Ratio Change
PRESS RELEASE

published on 04/19/2024 at 07:00, 2 years ago

Biophytis annonce un changement de ratio pour son programme d'American Depositary Receipt ('ADR')
Biophytis annonce un changement de ratio pour son programme d'American Depositary Receipt ('ADR'). La Société modifiera le ratio de ses ADS, passant de 1 ADS pour 100 Actions à 1 ADS pour 4 000 Actions

Biophytis Biotechnologie Société De Biotechnologie American Depositary Receipt Changement De Ratio
REGULATED PRESS RELEASE

published on 04/19/2024 at 07:00, 2 years ago

Biophytis annonce un changement de ratio pour son programme d'American Depositary Receipt (
Biophytis annonce un changement de ratio pour son programme d'American Depositary Receipt (ADR) le 23 avril 2024, entraînant un regroupement des ADS et une augmentation du prix de négociation

Biophytis American Depositary Receipt Changement De Ratio Regroupement D'ADS Prix De Négociation
REGULATED PRESS RELEASE

published on 04/19/2024 at 07:00, 2 years ago

Biophytis announces ratio change under its American Depositary Receipt (“ADR”) program
Biophytis announces ratio change for its American Depositary Receipt program, affecting ADS to Shares ratio. No new shares issued, trading price may increase. Details provided in the press release

Biophytis Shares Ads American Depositary Receipt Ratio Change
BRIEF

published on 04/18/2024 at 07:05, 2 years ago

Biophytis crée un Conseil Scientifique pour son étude sur l'obésité

Biophytis Conseil Scientifique Étude Clinique BIO101 Obésité
BRIEF

published on 04/18/2024 at 07:05, 2 years ago

Biophytis Announces New Scientific Advisory Board for Phase 2 Obesity Study

Biophytis Scientific Advisory Board BIO101 Obesity OBA Clinical Study

Published on 05/09/2026 at 01:55, 12 hours 40 minutes ago

Prospect Ridge Announces Board Resignation
Published on 05/09/2026 at 01:40, 12 hours 55 minutes ago

Findev Inc. Issues Corrective Disclosure
Published on 05/09/2026 at 01:30, 13 hours 5 minutes ago

Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 14 hours 35 minutes ago

Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/08/2026 at 23:01, 15 hours 34 minutes ago

Water Ways Announces Corporate Updates

View all ACCESSWIRE

Published on 05/08/2026 at 20:38, 17 hours 57 minutes ago

EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 19 hours 22 minutes ago

EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 19 hours 33 minutes ago

Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/08/2026 at 18:29, 20 hours 6 minutes ago

Designated Person Notification
Published on 05/08/2026 at 18:29, 20 hours 6 minutes ago

Designated Person Notification

View all EQS

Published on 05/07/2026 at 19:15, 1 day 19 hours ago

2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 1 day 19 hours ago

Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 1 day 19 hours ago

Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 1 day 19 hours ago

Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 1 day 19 hours ago

ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL

View all LES ECHOS COMFI WIRE

News